Do you want to read an article? Please log in or register.
First-line csDMARD monotherapy drug retention in psoriatic arthritis: methotrexate outperforms sulfasalazine
Psoriatic Arthritis
Related content
Psoriatic ArthritisFurther Publications Rheumatology
Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration
Ann Rheum Dis
Lindström U, Di Giuseppe D, Delcoigne B, Glintborg B, Möller B, Ciurea A, Pombo-Suarez M, Sanchez-Piedra C, Eklund K, Relas H, Gudbjornsson B, Love TJ, Jones GT, Codreanu C, Ionescu R, Nekvindova L, Závada J, Atas N, Yolbas S, Fagerli KM, Michelsen B, Rotar Ž, Tomšič M, Iannone F, Santos MJ, Avila-Ribeiro P, Ørnbjerg LM, Østergaard M, Jacobsson LT, Askling J, Nissen MJ
doi: 10.1136/annrheumdis-2021-220097
Psoriatic Arthritis
Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase 3 Trial
Arthritis Rheumatol.
Mease PJ, Gladman DD, Collier DH, Ritchlin CT, Helliwell PS, Liu L, Kricorian G, Chung JB
doi: 10.1002/art.40851.
Psoriatic Arthritis
Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-alpha inhibitor and methotrexate in early psoriatic arthritis: an open-label extension of a randomized placebo-controlled trial
Arthritis Res Ther.
de Jong HMY, van Mens LJJ, Nurmohamed MT, Kok MR, van Kuijk AWR, Baeten DLP, van de Sande MGH
doi: 10.1186/s13075-019-1998-4.
Atopic Dermatitis
Drug survival and post-drug survival of first-line immunosuppressive treatments for atopic dermatitis: comparison between methotrexate and cyclosporine
J Eur Acad Dermatol Venereol.
Law Ping Man S, Bouzillé G, Beneton N, Safa G, Dupuy A, Droitcourt C
doi: 10.1111/jdv.14880.
Psoriatic Arthritis
Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis
Rheumatology (Oxford).
Coates LC, Merola JF, Mease PJ, Ogdie A, Gladman DD, Strand V, van Mens LJJ, Liu L, Yen PK, Collier DH, Kricorian G, Chung JB, Helliwell PS
doi: 10.1093/rheumatology/
Juvenile Idiopathic Arthritis
Treat-to-target using first-line recombinant interleukin-1 receptor antagonist monotherapy in new-onset systemic juvenile idiopathic arthritis: results from a five year follow-up study
Arthritis Rheumatol.
Ter Haar NM, van Dijkhuizen EHP, Swart JF, van Royen-Kerkhof A, El Idrissi A, Leek AP, de Jager W, de Groot MCH, Haitjema S, Holzinger D, Foell D, van Loosdregt J, Wulffraat NM, de Roock S, Vastert SJ
doi: 10.1002/art.40865.
RECOMMENDED
Psoriasis
Complete resolution of erythrodermic psoriasis with first-line apremilast monotherapy
doi: 10.1136/bcr-2018-226959.
EULAR ® 2019
Psoriatic Arthritis
Psoriatic Arthritis
Mease et al. 2019. A randomized, phase III, double-blind trial examining methotrexate and etanercept as monotherapy or in combination for treating psoriatic arthritis: a comparison of the composite measures used to evaluate disease activity. Oral presentation presented at: EULAR 2019 Congress; 12–15 June 2019; Madrid, Spain.
COMMENTED
Psoriatic Arthritis
GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis
★ 1
Recommended and commented by
Dr Heino Prillwitz, Faculty Member
doi: 10.1136/annrheumdis-2019-216500.